Shionogi Announces Supplemental Approval in Japan for Pediatric Dosage and Administration of XOCOVA to Treat COVID-19 on June 19, 2026 COVID19 (disease) fumaric acid Japan Pediatric brand name pediatric dosage Phase 3 clinical trial shionogi supplemental approval Tablet Dosage Form Xocova +
Shionogi's COVID Antiviral Xocova Approved by FDA as Post‑Exposure Preventive for COVID-19 in the U.S. on June 01, 2026 Approved COVID19 (disease) ensitrelvir Injury due to exposure to external cause Post-Exposure Prophylaxis Prophylactic treatment shionogi United States Food and Drug Administration Xocova +
Live Friday: CDC Ends Universal COVID-19 Vaccine Recommendation – Anti-Vax Shift Under RFK Jr.? on April 23, 2026 ACIP Centers for Disease Control and Prevention (U.S.) COVID19 (disease) RFK gene universal recommendation Vaccines +
CHMP Recommends Moderna's mCombriax Flu-COVID Vaccine for Adults 50+ on March 02, 2026 Adult CHMP COVID19 (disease) Influenza mCombriax Moderna Multiple Acyl Coenzyme A Dehydrogenase Deficiency Vaccines +
N.Y. Attorney General Sues Former Emergent BioSolutions CEO Robert Kramer for Insider Trading on January 19, 2026 AstraZeneca COVID19 (disease) Emergent BioSolutions insider Letitia James New York AG Robert Kramer stock sales trading Vaccines +
FDA Commissioner Makary Addresses COVID-19 Vaccine Safety Concerns Amid Internal Debates and Investigations on December 17, 2025 Cautionary Warning COVID19 (disease) Marty Makary mRNA Vaccines Myocarditis RFK gene Safety United States Food and Drug Administration vaccine deaths Vaccines +
CDC highlights strong effectiveness of 2024–2025 COVID-19 shots in kids while FDA reviews reports of alleged post-vaccination deaths on December 12, 2025 Centers for Disease Control and Prevention (U.S.) Child COVID19 (disease) Effectiveness Emergency department patient visit Pediatrics United States Food and Drug Administration urgent care visits Vaccines +
FDA Broadens COVID-19 Vaccine Safety Probe to Adults Under New Health Leadership on December 10, 2025 Adult COVID19 (disease) Moderna Myocarditis Pfizer public trust safety review United States Food and Drug Administration vaccine deaths Vaccines +
FDA names Tracy Beth Heg as acting CDER chief on December 04, 2025 CDER Center for Drug Evaluation Chief COVID19 (disease) Drug Regulations Leadership research Tracy Beth Heg U.S. Food and Drug Administration United States Food and Drug Administration Vaccine Safety +
FDA Refuses to Release Detailed Data on Claimed COVID Vaccine-Linked Child Deaths in Near Term on December 03, 2025 COVID19 (disease) Data Release Death of child Myocarditis United States Food and Drug Administration vaccine oversight Vaccine Safety Vaccines +
Recent Developments on Vinay Prasad's Leaked FDA Memo, Alzheimer's Disease Updates, and Next-Gen Obesity Drugs on December 03, 2025 Alzheimer 's disease Cessation of life Child COVID19 (disease) next-generation Obesity research United States Food and Drug Administration Vaccines Vinay Prasad FDA memo +
FDA's Vinay Prasad Links 10 Child Deaths to COVID-19 Vaccines, Calls for Stricter Review Guidelines on December 01, 2025 Biological Factors COVID19 (disease) Death of child evaluation Myocarditis United States Food and Drug Administration vaccine guidelines vaccine regulation Vaccine Safety Vaccines VAERS Vinay Prasad +
Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx PCR Platform to Support Submission to the U.S. FDA on November 19, 2025 Clinical Evaluations Co-Diagnostics Co-Dx PCR platform COVID19 (disease) Flu A/B multiplex test point-of-care regulatory submission Respiratory syncytial virus United States Food and Drug Administration +
Pfizer Cuts 11 R&D Programs amid Ongoing Revenue Declines and Cost Realignment Efforts on November 05, 2025 Cost Savings COVID19 (disease) digital enablement earnings Pfizer Q3 R&D Revenue Decline Seagen acquisition +
CDC Updates COVID-19 and Chickenpox Vaccine Guidance Based on ACIP Recommendations on October 07, 2025 ACIP Centers for Disease Control and Prevention (U.S.) Chickenpox Chickenpox Vaccine COVID19 (disease) individual-based decision-making measles, mumps, rubella, varicella vaccine Vaccines +
CDC Advisors Shift COVID-19 Vaccine Guidance to Individual Decision-Making on September 22, 2025 ACIP Centers for Disease Control and Prevention (U.S.) Consultation COVID19 (disease) individual choice Provider Recommendation Vaccines +
RFK Jr. Names 8 New ACIP Members, Replacing Prior Committee Before Key Vaccine Votes on September 16, 2025 ACIP Centers for Disease Control and Prevention (U.S.) COVID19 (disease) measles RFK Jr. Robert F. Kennedy Jr. Shakeup vaccine advisors Vaccine Safety +
RFK Jr. Blasts Pharma Industry and Spreads mRNA Vaccine Misinformation During Heated Senate Hearing on September 08, 2025 Centers for Disease Control and Prevention (U.S.) COVID19 (disease) Leadership mRNA misinformation Pharma Industry Policy public health medicine (field) RFK Jr. Senate hearing Vaccines +
Vinay Prasad Details New Approach to COVID-19 Vaccine Approvals in Recent FDA Memos on September 02, 2025 Child COVID19 (disease) Evidence Prasad regulatory decisions risk-benefit analysis Spikevax United States Food and Drug Administration vaccine approval Vaccine Safety Vaccines Vinay +
FDA Approves Updated COVID-19 Shots from Pfizer, Moderna, Novavax with New Restrictions on August 29, 2025 COVID19 (disease) high-risk groups LP.8.1 sublineage Moderna Novavax Pfizer Restrictions United States Food and Drug Administration Vaccines +